5.10% p.a. Early Redemption Worst of GOAL

Underlying: Biogen Idec / Novo Nordisk / Shire SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 41051278 / ISIN: CH0410512781

Last update 12.11.2018
  • Bid

    99.58 %
    Volume: 100'000

  • Ask

    100.58 %
    Volume: 100'000